Lee Clara Nan-Hi, Deal Allison M, Huh Ruth, Ubel Peter Anthony, Liu Yuen-Jong, Blizard Lillian, Hunt Caprice, Pignone Michael Patrick
Department of Plastic Surgery, College of Medicine, The Ohio State University, Columbus.
Richard J. Solove Research Institute, Comprehensive Cancer Center-Arthur G. James Cancer Hospital, The Ohio State University, Columbus.
JAMA Surg. 2017 Aug 1;152(8):741-748. doi: 10.1001/jamasurg.2017.0977.
Breast reconstruction has the potential to improve a person's body image and quality of life but has important risks. Variations in who undergoes breast reconstruction have led to questions about the quality of patient decisions.
To assess the quality of patient decisions about breast reconstruction.
DESIGN, SETTING, AND PARTICIPANTS: A prospective, cross-sectional survey study was conducted from June 27, 2012, to February 28, 2014, at a single, academic, multidisciplinary oncology clinic among women planning to undergo mastectomy for stage I to III invasive ductal or lobular breast cancer, ductal carcinoma in situ, or prophylaxis.
Mastectomy only and mastectomy with reconstruction.
Knowledge, as ascertained using the Decision Quality Instrument; preference concordance, based on rating and ranking of key attributes; and decision quality, defined as having knowledge of 50% or more and preference concordance.
During the 20-month period, 214 patients were eligible, 182 were approached, and 32 missed. We enrolled 145 patients (79.7% enrollment rate), and received surveys from 131 patients (72.0% participation rate). Five participants became ineligible. The final study population was 126 patients. Among the 126 women in the study (mean [SD] age, 53.2 [12.1] years), the mean (SD) knowledge score was 58.5% (16.2%) and did not differ by treatment group (mastectomy only, 55.2% [15.0%]; mastectomy with reconstruction, 60.5% [16.5%]). A total of 82 of 123 participants (66.7%) had a calculated treatment preference of mastectomy only; 39 of these women (47.6%) underwent mastectomy only. A total of 41 participants (32.5%) had a calculated treatment preference of mastectomy with reconstruction; 36 of these women (87.8%) underwent mastectomy with reconstruction. Overall, 52 of 120 participants (43.3%) made a high-quality decision. In multivariable analysis, white race/ethnicity (odds ratio [OR], 2.72; 95% CI, 1.00-7.38; P = .05), having private insurance (OR, 1.61; 95% CI, 1.35-1.93; P < .001), having a high school education or less (vs some college) (OR, 4.84; 95% CI, 1.22-19.21; P = .02), having a college degree (vs some college) (OR, 1.95; 95% CI, 1.53-2.49; P < .001), and not having a malignant neoplasm (eg, BRCA carriers) (OR, 3.13; 95% CI, 1.25-7.85; P = .01) were independently associated with making a high-quality decision.
A minority of patients undergoing mastectomy in a single academic center made a high-quality decision about reconstruction. Shared decision making is needed to support decisions about breast reconstruction.
乳房重建有可能改善一个人的身体形象和生活质量,但也存在重大风险。接受乳房重建的人群差异引发了关于患者决策质量的问题。
评估患者关于乳房重建决策的质量。
设计、地点和参与者:2012年6月27日至2014年2月28日,在一家单一的学术性多学科肿瘤诊所,对计划因I至III期浸润性导管癌或小叶癌、导管原位癌或预防性切除乳房的女性进行了一项前瞻性横断面调查研究。
单纯乳房切除术和乳房切除术后重建。
使用决策质量工具确定的知识水平;基于关键属性的评分和排序得出的偏好一致性;决策质量定义为知晓率达到50%或更高且偏好一致。
在20个月期间,214名患者符合条件,182名患者被邀请,32名患者未参与。我们纳入了145名患者(纳入率79.7%),并收到了131名患者的调查问卷(参与率72.0%)。5名参与者不符合条件。最终研究人群为126名患者。在研究的126名女性中(平均[标准差]年龄,53.2[12.1]岁),平均(标准差)知识得分是58.5%(16.2%),且不同治疗组之间无差异(单纯乳房切除术,55.2%[15.0%];乳房切除术后重建,60.5%[16.5%])。123名参与者中有82名(66.7%)计算得出的治疗偏好是单纯乳房切除术;这些女性中有39名(47.6%)接受了单纯乳房切除术。41名参与者(32.5%)计算得出的治疗偏好是乳房切除术后重建;这些女性中有36名(87.8%)接受了乳房切除术后重建。总体而言,120名参与者中有52名(43.3%)做出了高质量决策。在多变量分析中,白人种族/民族(优势比[OR],2.72;95%置信区间,1.00 - 7.38;P = 0.05)、拥有私人保险(OR,1.61;95%置信区间,1.35 - 1.93;P < 0.001)、高中及以下学历(相对于部分大学学历)(OR,4.84;95%置信区间,1.22 - 19.21;P = 0.02)、拥有大学学位(相对于部分大学学历)(OR,1.95;95%置信区间,1.53 - 2.49;P < 0.001)以及没有恶性肿瘤(如BRCA携带者)(OR,3.13;95%置信区间,1.25 - 7.85;P = 0.01)与做出高质量决策独立相关。
在一个单一学术中心接受乳房切除术的患者中,少数人对重建做出了高质量决策。需要共同决策来支持关于乳房重建的决策。